SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients

SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients

Summary: In a published case-control study (GSE152075) from SARS-CoV-2-positive (n = 403) and -negative patients (n = 50), we analyzed the response to infection assessing gene expression of host cell receptors and antiviral proteins. The expression analysis associated with reported risk factors for...

Full description

Bibliographic Details
Main Authors: Juan Bizzotto, Pablo Sanchis, Mercedes Abbate, Sofía Lage-Vickers, Rosario Lavignolle, Ayelén Toro, Santiago Olszevicki, Agustina Sabater, Florencia Cascardo, Elba Vazquez, Javier Cotignola, Geraldine Gueron
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:iScience
Subjects:
Health Informatics
Virology
Online Access:http://www.sciencedirect.com/science/article/pii/S258900422030777X

Internet

http://www.sciencedirect.com/science/article/pii/S258900422030777X

Similar Items